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Profile of Qi Zhou 
 
Dr. Qi Zhou received his Ph.D. degree in Histology and 
Embryology from Northeast Agricultural University, China, 
in 1996. He then joined the Institute of Developmental Bi-
ology, Chinese Academy of Sciences (CAS), as a postdoc-
toral fellow, and was qualified as associate professor two 
years later. In 1999, he joined Prof. Jean-Paul Renard’s 
group at the Developmental Biology and Reproduction Unit 
of the French National Institute for Agricultural Research 
(INRA) as a postdoctoral fellow. He soon led several re-
searchers working on an animal cloning project, and, among 
other animals they cloned, produced the world’s first cloned 
rat. In 2002, with the support of the CAS Hundred Talents 
Program, Dr. Zhou went back to China to join the Institute 
of Zoology, CAS, as a professor, and set up his own re-
search laboratory. In 2005, he received the National Science 
Fund for Distinguished Young Scholars from the National 
Natural Science Foundation of China. Dr. Zhou is currently 
a professor and deputy director of the Institute of Zoology, 
CAS, and is the director of the State Key Laboratory of 
Stem Cell and Reproductive Biology (formerly the State 
Key Laboratory of Reproductive Biology). In 2015, he was 
elected as a CAS Member. 
Since he came back to China, Dr. Zhou has focused on 
stem cell research and has led a group carrying out a series 
of projects in the field of stem cell biology, with emphasis 
on studying the mechanisms of cell reprogramming and 
pluripotency of embryonic stem cells. He has also promoted 
the translation of stem cells to clinical applications. During 
the past years, Dr. Zhou has made many outstanding 
achievements.  
Developing novel methods for somatic cell reprogram-
ming 
In the 1990’s and the early 21st century, when cloning tech- 
nology was in its early stages, Dr. Zhou was the first to de-
velop a one-step somatic cell nuclear transfer (SCNT) 
method (Zhou et al., 2000), and used a protease inhibitor to 
prevent rat oocytes from spontaneous but incomplete acti-
vation. This allowed him to generate the world’s first fertile 
cloned rats. The work was published in Science (Zhou et al.,  
 
 
2003) and received comments stating that it was “a signifi- 
cant step toward” producing genetically modified rats, and 
that it would help study many human diseases. For this 
work, Dr. Zhou won the 3rd genOway Prize for transgenic 
technologies. 
The advent of iPSC (induced pluripotent stem cell) tech-
nology greatly advanced the development of stem cell and 
cell reprogramming research. However, whether iPSCs have 
developmental pluripotency was one of the most challeng-
ing questions in the field. By optimizing induction protocols 
and establishing new induction and culture methods for iP-
SCs, research groups led by Dr. Qi Zhou and Dr. Fanyi 
Zeng efficiently obtained stable iPSC lines. After injecting 
iPSCs into tetraploid blastocysts, they obtained healthy 
iPSC-generated mice and offspring through tetraploid com-
plementation (Zhao et al., 2009). The work demonstrated 
that iPSCs are capable of producing healthy organisms in-
dependently, and therefore hold the same developmental 
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potential as embryonic stem cells (ESCs). This work made 
outstanding contributions to the improvement of iPSC the-
ory and to future applications of iPSCs in regenerative 
medicine, and was reported on by hundreds of media outlets 
worldwide, including Nature, Science, Times, and Reuters, 
among others. The paper published in Nature reporting this 
work has been cited more than 480 times to date. The first 
iPSC-produced mouse, “Xiao Xiao”, was considered to 
have “received the torch lit by Dolly”. The work was se-
lected as one of TIME’s Top 10 Medical Breakthroughs of 
2009, and one of the Top 10 Breakthroughs in Science and 
Technology of 2009, in China. 
Dr. Zhou and his team also successfully reprogrammed 
Sertoli cells of the mesoderm layer into neural stem cells of 
the ectoderm layer (Sheng et al., 2012). A series of marker 
expression and functional analyses demonstrated that adult 
cells of different germ layers might achieve transdifferentia-
tion. This finding has an enlightening significance in study-
ing the mechanisms of organ formation. It also suggests that 
neural stem cells, derived through such induction, might 
become a resource for cells used in the treatment of neuro-
degenerative diseases and for screening new drugs.  
Investigating the mechanisms of cell reprogramming 
and cell fate control 
Dr. Zhou and his team discovered that a histone deacetylase 
inhibitor, CBHA, could increase the efficiency of cell re-
programming by nuclear transfer, suggesting that histone 
deacetylation may play an important role in regulating cell 
reprogramming (Dai et al., 2010). They also conducted 
long-term investigations and found that tumor prevalence in 
adult iPSC-generated mice was much higher than that of 
control mice, suggesting that the endogenous oncogenic risk 
of iPSCs is associated with the re-activation of their induc-
tion factors (Tong et al., 2011). 
Through systematically examining and analyzing plu-
ripotent stem cell lines of different developmental poten-
cies, Dr. Zhou and his team discovered a key generegulation 
region, the expression of which is positively correlated to 
the stem cell pluripotency level. Therefore, this region may 
serve as a molecular marker for evaluating the pluripotency 
of stem cells (Liu et al., 2010). The work was published as 
the cover image and “Paper of the Week” in the Journal of 
Biological Chemistry in 2010, and garnered great attention 
from international peers. The American Society for Bio-
chemistry and Molecular Biology (ASBMB) pointed out 
that the “Finding is expected to steer future work on thera-
pies down the most efficient and promising paths”. The 
team also discovered that miR-323-3p, of the above im-
printing region, could influence the pluripotency level of 
stem cells by regulating the PRC2 complex (Zhang et al., 
2013). 
In collaboration with the teams of Drs. Xiujie Wang and 
Yungui Yang, Dr. Zhou discovered a new function for mi-
croRNAs in regulating the formation of N6-methyladeno- 
sine (m6A) RNA modification and a positive role for m6A in 
promoting cell reprogramming to pluripotency (Chen et al., 
2015). 
Generating important animal and cell models for stem 
cell research and regenerative medicine 
Haploid cells exist in many plant species and are an im-
portant tool used extensively for studying recessive traits 
and breeding. However, in mammalians, only gametes or 
tumor cells with gene mutations are haploid. Dr. Zhou and 
his team derived mammalian androgenetic and parthenoge-
netic haploid embryonic stem cells (ahESCs and phESCs, 
respectively), and showed that ahESCs can replace gametes 
to produce offspring. The work not only demonstrated the 
developmental pluripotency of ahESCs, but also provided 
new tools for the rapid generation of genetic models for 
recessive traits; it also shed new light on assisted reproduc-
tion. This series of work was published in Nature and Cell 
Stem Cell, among others. (Li et al., 2012; Wan et al., 2013; 
Li et al., 2014), was co-selected (with work from another 
team) as one of China’s top 10 Scientific Advances in 2012. 
Recently, Dr. Zhou’s group showed that after proper im-
printing modifications, mouse phESCs can efficiently pro-
duce viable fertile offspring upon intracytoplasmic injection 
into MII oocytes (Li et al., 2016), thus establishing a novel 
strategy for generating bimaternal mammals. This is valua-
ble to uncover the function of genomic imprinting, and to 
improve assisted reproduction in diverse mammalian spe-
cies.  
In addition, Zhou and his team generated mouse-rat allo-
diploid embryonic stem cells (AdESCs) by fusing haploid 
ESCs of two species. This was the world’s first mammalian 
diploid hybrid ESC of phylogenetically distal species. This 
will be a valuable tool for studying X chromosome inactiva-
tion and genes with functional differences between species. 
The work was published in Cell in January 2016 (Li et al., 
2016). 
Transgenic animal models may establish new phenotypes 
through gain or loss of function of genes, and are necessary 
tools for studying gene functions and the pathogenesis of 
diseases. With the platform of the CRISPR-Cas9 system, 
Dr. Zhou and his team achieved simultaneous mutations of 
multiple genes in rats (Li et al., 2013), generated live vWF- 
knockout pig models using a one-step method (Hai et al., 
2014), and produced the first live p53 homozygous mutant 
monkey (Wan et al., 2015). These studies provide a new 
approach for rapid generation of genetically modified ani-
mal models of human diseases, and will promote research 
on pathogenesis and treatment of diseases. 
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Obtaining standardized and scalable seed cells for 
therapeutic use, and carrying out evaluations of 
pre-clinical safety and efficacy  
Safety and efficacy remain two primary concerns when ap-
plying cell therapy to clinical use. How to combine basic 
research with clinical application, how to evaluate the effi-
cacy and safety of cells used for therapy, and how to com-
ply with clinical standards, are major research focuses. 
During recent years, Dr. Zhou has been working on estab-
lishing Beijing Stem Cell Bank that is in accordance with 
clinical standards, has performed rigorous cell safety tests, 
and has formulated an entire set of relevant rules and regu-
lations. He has also promoted the formulation of interna-
tional guidelines for the clinical application of stem cells 
and promoted the implementation of international action 
schemes related to stem cells. 
Dr. Zhou’s distinguished work has resulted in over 100 
publications, many of which were published in top-ranked 
scientific journals, including Cell, Nature, Science, Nature 
Biotechnology, Cell Stem Cell, and PNAS. He has been 
awarded many prizes, including the Second Class Award of 
the National Natural Science Award of China (2014), the 
Outstanding Science and Technology Achievement Prize of 
the CAS (2013), and the Prize for Scientific and Techno-
logical Progress from the Ho Leung Ho Lee Foundation 
(2010). 
Apart from his academic achievements, Dr. Qi Zhou also 
takes great responsibility for, and makes many contributions 
to, the entire stem cell research society in China. He serves 
as a consultant for the China Ministry of Science in the 
Program of Development and Reproduction and Technolo-
gy. He promoted the setup of the Strategic Priority Research 
Project of Stem Cell and Regenerative Medicine of the 
Chinese Academy of Sciences, and serves as the chief sci-
entist to coordinate the research of over 80 stem cell biolo-
gists. After being invited to the International Stem Cell Fo-
rum, as the representative of China, of which he currently 
serves as the president, Dr. Zhou took this responsibility 
and organized four international workshops related to stem 
cell study and regulation. This not only strengthened the 
collaboration between China and other countries but also 




Chen, T., Hao, Y., Zhang, Y., Li, M., Wang, M., Han, W., Wu, Y., Lv, Y., 
Hao, J., Wang, L., Li, A., Yang, Y., Jin, K., Zhao, X., Li, Y., Ping, X., 
Lai, W., Wu, L., Jiang, G., Wang, H., Sang, L., Wang, X., Yang, Y., 
and Zhou, Q. (2015). m6A RNA methylation is regulated by mi-
croRNAs and promotes reprogramming to pluripotency. Cell Stem Cell 
16, 289301. 
Dai, X., Hao, J., Hou, X., Hai, T., Fan, Y., Yu, Y., Jouneau, A., Wang, L., 
and Zhou, Q. (2010). Somatic nucleus reprogramming is significantly 
improved by m-carboxycinnamic acid bishydroxamide (CBHA), a his-
tone deacetylase inhibitor. J Biol Chem 285, 3100231010. 
Hai, T., Teng, F., Guo, R., Li, W., and Zhou, Q. (2014). One-step genera-
tion of knockout pigs by zygote injection of CRISPR/Cas system. Cell  
Res 24, 372375. 
Li, W., Shuai, L., Wan, H., Dong, M., Wang, M., Sang, L., Feng, C., Luo, 
G., Li, T., Li, X., Wang, L., Zheng, Q., Sheng, C., Wu, H., Liu, Z., Liu, 
L., Wang, L., Wang, X., Zhao, X., and Zhou, Q. (2012). Androgenetic 
haploid embryonic stem cells produce live transgenic mice. Nature 490, 
407411. 
Li, W., Teng, F., Li, T., and Zhou, Q. (2013). Simultaneous generation and 
germline transmission of multiple gene mutations in rat using 
CRISPR-Cas systems. Nat Biotechnol 31, 684–686. 
Li, W., Li, X., Li, T., Jiang, M., Wan, H., Luo, G., Feng, C., Cui, X., Teng, 
F., Yuan, Y., Zhou, Q., Gu, Q., Shuai, L., Sha, J., Xiao, Y., Wang, L., 
Liu, Z., Wang, X., Zhao, X., and Zhou, Q. (2014). Genetic modification  
and screening in rat using haploid embryonic stem cells. Cell Stem Cell 
14, 404414. 
Li, X., Cui, X., Wang, J., Wang, Y., Li, Y., Wang, L., Wan, H., Li, T., 
Feng, G., Shuai, L., Li, Z., Gu, Q., Hao, J., Wang, L., Zhao, X., Liu, Z., 
Wang, X., Li, W., and Zhou, Q. (2016). Generation and application of 
mouse-rat allodiploid embryonic stem cells. Cell 164, 279–292. 
Li, Z., Wan, H., Feng, G., Wang, L., He, Z., Wang, Y., Wang, X., Li, W., 
Zhou, Q., and Hu, B. (2016). Birth of fertile bimaternal offspring fol-
lowing intracytoplasmic injection of parthenogenetic haploid embryon-
ic stem cells. Cell Res 26, 135–138. 
Liu, L., Luo, G., Yang, W., Zhao, X., Zheng, Q., Lv, Z., Li, W., Wu, H., 
Wang, L., Wang, X., and Zhou, Q. (2010). Activation of the imprinted 
Dlk1-Dio3 region correlates with pluripotency levels of mouse stem 
cells. J Biol Chem 285, 19483–19490. 
Sheng, C., Zheng, Q., Wu, J., Xu, Z., Wang, L., Li, W., Zhang, H., Zhao, 
X., Liu, L., Wang, Z., Guo, C., Wu, H., Liu, Z., Wang, L., He, S., 
Wang, X., Chen, Z., and Zhou, Q. (2012). Direct reprogramming of 
Sertoli cells into multipotent neural stem cells by defined factors. Cell 
Res 22, 208–218. 
Tong, M., Lv, Z., Liu, L., Zhu, H., Zheng, Q., Zhao, X., Li, W., Wu, Y., 
Zhang, H., Wu, H., Li, Z., Zeng, F., Wang, L., Wang, X., Sha, J., and 
Zhou, Q. (2011). Mice generated from tetraploid complementation 
competent iPS cells show similar developmental features as those from 
ES cells but are prone to tumorigenesis. Cell Res 21, 1634–1637. 
Wan, H., He, Z., Dong, M., Gu, T., Luo, G., Teng, F., Xia, B., Li, W., 
Feng, C., Li, X., Li, T., Shuai, L., Fu, R., Wang, L., Wang, X., Zhao, 
X., and Zhou, Q. (2013). Parthenogenetic haploid embryonic stem cells 
produce fertile mice. Cell Res 23, 1330–1333. 
Wan, H., Feng, C., Teng, F., Yang, S., Hu, B., Niu, Y., Xiang, A., Fang, 
W., Ji, W., Li, W., Zhao, X., and Zhou, Q. (2015). One-step generation 
of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas 
system. Cell Res 25, 258–261. 
Zhang, Y., Teng, F., Luo, G., Wang, M., Tong, M., Zhao, X., Wang, L., 
Wang, X., and Zhou, Q. (2013). MicroRNA-323-3p regulates the activ-
ity of polycomb repressive complex 2 (PRC2) via targeting the mRNA 
of embryonic ectoderm development (Eed) gene in mouse embryonic 
stem cells. J Biol Chem 288, 23659–23665. 
Zhao, X., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C., Ma, 
Q., Wang, L., Zeng, F., and Zhou, Q. (2009). iPS cells produce viable 
mice through tetraploid complementation. Nature 461, 86–90. 
Zhou, Q., Boulanger, L., and Renard, J.P. (2000). A simplified method for 
the reconstruction of fully competent mouse zygotes from adult somatic 
donor nuclei. Cloning 2, 35–44. 
Zhou, Q., Renard, J.P., Le Friec, G., Brochard, V., Beaujean, N., Cherifi, 
Y., Fraichard, A., and Cozzi, J. (2003). Generation of fertile cloned rats 
by regulating oocyte activation. Science 302, 1179. 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
